| |
| |
|
| Insider
Information: |
Gryska David W |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
174,851 |
|
|
Indirect Shares
|
750 |
|
|
| Direct
Value |
$984,634 |
|
|
|
Indirect Value
|
$81,180 |
|
|
| Total
Shares |
175,601 |
|
|
| Total
Value |
$1,065,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 15.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2006-02-14 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
Chief Financial Officer |
2010-05-04 |
864 |
2010-05-04 |
750 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2020-12-30 |
1,387 |
2014-03-06 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Executive Vice Preside... |
2018-07-16 |
10,235 |
2015-01-08 |
0 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2022-11-21 |
0 |
2022-11-21 |
0 |
Premium* |
|
|
Mind Medicine |
MNMD |
Director |
2023-06-21 |
13,851 |
2023-06-21 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Director |
2023-07-31 |
148,514 |
2023-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2013-09-03 |
4 |
OE |
$10.08 |
$100,800 |
D/D |
10,000 |
32,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-09-06 |
4 |
OE |
$10.20 |
$102,000 |
D/D |
10,000 |
37,650 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-01-08 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-04-01 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-07-17 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
53,013 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-10-01 |
4 |
OE |
$12.76 |
$79,450 |
D/D |
5,000 |
50,513 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2022-11-21 |
4 |
D |
$15.25 |
$175,299 |
D/D |
(11,495) |
0 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2022-11-21 |
4 |
D |
$15.25 |
$30,439 |
I/I |
(1,996) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2011-12-09 |
4 |
S |
$18.09 |
$180,917 |
D/D |
(10,000) |
15,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-11-19 |
4 |
OE |
$19.02 |
$285,300 |
D/D |
15,000 |
52,719 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2012-06-05 |
4 |
S |
$19.75 |
$158,000 |
D/D |
(8,000) |
11,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-01-14 |
4 |
OE |
$20.06 |
$90,270 |
D/D |
4,500 |
50,750 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-01-28 |
4 |
OE |
$20.06 |
$90,270 |
D/D |
4,500 |
46,464 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-02-07 |
4 |
OE |
$20.06 |
$90,270 |
D/D |
4,500 |
48,621 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-04-19 |
4 |
OE |
$20.06 |
$80,240 |
D/D |
4,000 |
46,940 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-02-25 |
4 |
S |
$27.17 |
$271,700 |
D/D |
(10,000) |
8,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-02-13 |
4 |
OE |
$36.70 |
$321,125 |
D/D |
8,750 |
49,003 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-04 |
4 |
OE |
$39.01 |
$294,489 |
D/D |
6,458 |
3,013 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-09-03 |
4 |
S |
$42.48 |
$424,800 |
D/D |
(10,000) |
22,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-11-05 |
4 |
S |
$43.57 |
$435,737 |
D/D |
(10,000) |
23,950 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-03 |
4 |
OE |
$49.61 |
$1,653,025 |
D/D |
32,499 |
7,499 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
OE |
$57.58 |
$1,339,541 |
D/D |
23,264 |
23,264 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-04 |
4 |
S |
$60.00 |
$335,640 |
D/D |
(5,594) |
864 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-03 |
4 |
S |
$61.63 |
$2,003,073 |
D/D |
(32,499) |
0 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
S |
$64.50 |
$1,500,528 |
D/D |
(23,264) |
0 |
0 |
- |
|
104 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
